SciSparc Shares Are Trading Higher After the Company Submitted an Investigational New Drug (IND) Application to the FDA for SCI-110
SciSparc股价上涨,原因是公司向FDA提交了SCI-110的临床试验申请(IND)。
SciSparc Shares Are Trading Higher After the Company Submitted an Investigational New Drug (IND) Application to the FDA for SCI-110
SciSparc股价上涨,原因是公司向FDA提交了SCI-110的临床试验申请(IND)。
使用浏览器的分享功能,分享给你的好友吧